Lymphatic Vessels in Tumor Dissemination versus Immunotherapy.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 32605997.
- Also identified by DOI 10.1158/0008-5472.CAN-20-0156.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
During the growth of various cancers, primary tumors can escape antitumor immune responses of their host and eventually disseminate into distant organs. Peritumoral lymphatic vessels connect the primary tumor to lymph nodes, facilitating tumor entry into lymph nodes, systemic circulation, and metastasis. Lymph node metastases that occur frequently provide sites of tumor cell spread, whereas tumor antigen transfer into and presentation in tumor-draining lymph nodes induce activation of tumor-specific T-lymphocyte responses that can result in cytolytic targeting of the tumor. Here, we discuss the recently emerged controversial role of the lymphatic vessels in tumor dissemination and cancer immunotherapy.
Medical subject headings
- Immunotherapy
- Lymphatic Metastasis
- Lymphatic Vessels